Japanese patent granted for IntelliGel platform
August 30, 2016 12:00 pmThe granting of a Japanese patent for the IntelliGel® platform opens a significant global market within ophthalmic medicines to Redwood... View Article
The granting of a Japanese patent for the IntelliGel® platform opens a significant global market within ophthalmic medicines to Redwood... View Article
On October 20th, Redwood Pharma AB (publ.) will present at the French-Swedish Life Science Day organized by Business Sweden, the... View Article
The 8th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance will occur from September... View Article
Redwood Pharma attending OIS-ASRS Conference in San Francisco Redwood Pharma AB (publ) announces that it will be attending the Ophthalmology... View Article
Redwood Pharma AB (publ) has been invited to the BIO 2016 conference to present Redwood Pharma’s drug candidate RP101 and... View Article
Stockholm, Sweden – Redwood Pharma AB has completed a SEK 6.6 million private placement to fund development of its lead product... View Article
Stockholm, Sweden – Redwood Pharma AB has entered into a licensing agreement with Broda Technologies Co., Ltd., operating in both the... View Article